The University of Southampton
University of Southampton Institutional Repository

Intensive insulin therapy in the intensive care unit, hypoglycemia and cardiovascular mortality

Intensive insulin therapy in the intensive care unit, hypoglycemia and cardiovascular mortality
Intensive insulin therapy in the intensive care unit, hypoglycemia and cardiovascular mortality
Several studies have shown that elevated glucose concentrations in patients with acute coronary syndrome and other acute severe illnesses are associated with increased short- and long-term all-cause and cardiovascular mortality (CVM). This has subsequently led to the use of intensive insulin therapy (IIT) to control hyperglycemia.

Earlier studies have shown that the prevention of hyperglycemia in acute illness through the use of IIT reduces mortality. More recent studies have failed to confirm this benefit, and in some cases IIT was associated with increased all-cause mortality. The reason for these discrepant results is not clear, although accumulating evidence suggests that the higher prevalence of insulin-induced hypoglycemia associated with IIT may be responsible.

This has led to the development of guidelines from the American Heart Association and American Diabetes Association, which recommend IIT for in-patient control of hyperglycemia but also add the caveat that “care should be taken to avoid hypoglycemia.” Despite this advice, however, the rates of hypoglycemia in patients receiving IIT continue to be as high as 19%. Although the physiological basis for this “paradox” is unclear, hypoglycemia is considered to be a putative cause.

A strong association between hypoglycemia and adverse cardiovascular events has been observed in several studies. This article will encompass the various studies that have used IIT to treat patients during acute illnesses. Furthermore, it will aim to provide a mechanistic basis for the observed association between hypoglycemia and CVM.
endothelin, hypoglycemia, insulin, cardiovascular mortality
0018-5809
59-66
Rana, Omar
a9ba783e-d783-42ff-978c-2334b4a77a0d
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Greaves, Kim
176a04cc-a3b0-451d-9d2e-59db4cde71c7
Rana, Omar
a9ba783e-d783-42ff-978c-2334b4a77a0d
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Greaves, Kim
176a04cc-a3b0-451d-9d2e-59db4cde71c7

Rana, Omar, Byrne, Christopher D. and Greaves, Kim (2010) Intensive insulin therapy in the intensive care unit, hypoglycemia and cardiovascular mortality. Hospital Practice, 38 (2), 59-66. (doi:10.3810/hp.2010.04.295).

Record type: Article

Abstract

Several studies have shown that elevated glucose concentrations in patients with acute coronary syndrome and other acute severe illnesses are associated with increased short- and long-term all-cause and cardiovascular mortality (CVM). This has subsequently led to the use of intensive insulin therapy (IIT) to control hyperglycemia.

Earlier studies have shown that the prevention of hyperglycemia in acute illness through the use of IIT reduces mortality. More recent studies have failed to confirm this benefit, and in some cases IIT was associated with increased all-cause mortality. The reason for these discrepant results is not clear, although accumulating evidence suggests that the higher prevalence of insulin-induced hypoglycemia associated with IIT may be responsible.

This has led to the development of guidelines from the American Heart Association and American Diabetes Association, which recommend IIT for in-patient control of hyperglycemia but also add the caveat that “care should be taken to avoid hypoglycemia.” Despite this advice, however, the rates of hypoglycemia in patients receiving IIT continue to be as high as 19%. Although the physiological basis for this “paradox” is unclear, hypoglycemia is considered to be a putative cause.

A strong association between hypoglycemia and adverse cardiovascular events has been observed in several studies. This article will encompass the various studies that have used IIT to treat patients during acute illnesses. Furthermore, it will aim to provide a mechanistic basis for the observed association between hypoglycemia and CVM.

This record has no associated files available for download.

More information

Published date: April 2010
Related URLs:
Keywords: endothelin, hypoglycemia, insulin, cardiovascular mortality

Identifiers

Local EPrints ID: 149603
URI: http://eprints.soton.ac.uk/id/eprint/149603
ISSN: 0018-5809
PURE UUID: f19faa43-bbdd-43b3-8dbb-222e89702f04
ORCID for Christopher D. Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 30 Apr 2010 14:25
Last modified: 14 Mar 2024 02:43

Export record

Altmetrics

Contributors

Author: Omar Rana
Author: Kim Greaves

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×